Gastric adenocarcinoma is a malignant tumor that develops in the innermost layer (mucosa) of the stomach and accounts for more than 90% of cases of this type. Stomach cancer is the sixth most common ...

Researchers at Case Western Reserve University have discovered molecules that present the potential to drive the development ...

has revealed that he has a form of stomach cancer. On Saturday, Feb. 15, the 43-year-old retired MLB player revealed his Stage 4 adenocarcinoma diagnosis in an interview with MLB.com, amid the ...

Teresa Tiano was diagnosed with stomach cancer in 2011. Now she's helping others Canadians with "the orphan cancer." ...

Enhertu already has seven FDA approvals across breast cancer, gastric cancer, non-small cell lung cancer (NSCLC), and ...

The use of indocyanine green (ICG)-guided lymphadenectomy was associated with improved overall survival (OS) and ...

AstraZeneca and Daiichi Sankyo's Enhertu has become the first HER2-directed drug to mount a patient survival benefit in a ...

Enhertu improved overall survival versus chemotherapy in HER2-positive metastatic gastric cancer, prompting an interim ...

The following is a summary of "Relationship between gastric mucosal atrophy, cystic dilatation, and histopathological ...

A new study published in JAMA determined that the addition of sugemalimab to chemotherapy enhances overall and ...

MATTERHORN is the first global phase 3 trial to show improved event-free survival with an immunotherapy combo vs standard ...